Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 110078-46-1 | Product Number: P2678
Plerixafor
×
![]()
×
Purity: >98.0%(GC)
Synonyms:
- 1,4-Bis[(1,4,8,11-tetraazacyclotetradecan-1-yl)methyl]benzene
- AMD 3100
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 50MG |
£66.00
|
1 | 6 |
|
| 250MG |
£224.00
|
Contact Us | 10 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
| Product Number | P2678 |
| Purity / Analysis Method | >98.0%(GC) |
| Molecular Formula / Molecular Weight | C__2__8H__5__4N__8 = 502.80 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Hygroscopic,Heat Sensitive |
| CAS RN | 110078-46-1 |
| Reaxys Registry Number | 4278367 |
| PubChem Substance ID | 468592671 |
| MDL Number | MFCD05662218 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(GC) | min. 98.0 % |
| Melting point | 131.0 to 135.0 °C |
| Water | max. 13.0 % |
Properties (reference)
| Melting Point | 133 °C |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| Precautionary Statements | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
Related Laws:
Transport Information:
| HS Number | 2933998090 |
Application
Plerixafor: A CXCR4 Chemokine Receptor Inhibitor and a Stem Cell Mobilization Agent
Plerixafor (AMD1300) was originally discovered as an anti-HIV agent effective in inhibiting the replication of HIV.1) However, at present, plerixafor has been used as a CXCR4 chemokine receptor inhibitor and a hematopoietic stem cell mobilization agent.2,3) Hematopoietic stem cells express CXCR4, a seven-transmembrane G-protein-coupled chemokine receptor. Plerixafor works as a CXCR4 chemokine receptor antagonist and blocks binding of its cognate ligand, stromal cell-derived factor-1α (SDF-1α). CXCR4 with its ligand SDF-1α has been reported to play an important role in engraftment of hematopoietic stem cells (HSCs) in the bone marrow. Plerixafor results in the rapid and reversible mobilization of hematopoietic stem cells into the peripheral circulation. (The product is for research purpose only.)
References
- 1) Synthesis and Structure-Activity Relationships of Phenylenebis(methylene)-Linked Bis-Tetraazamacrocycles That Inhibit HIV Replication. Effects of Macrocyclic Ring Size and Substituents on the Aromatic Linker
- 2) CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers (a review)
- 3) Physiology and Pharmacology of Plerixafor (a review)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.